Hunan Kelun Pharmaceutical

Clinical trials sponsored by Hunan Kelun Pharmaceutical, explained in plain language.

Now part of Sichuan Kelun Pharmaceutical Co., Ltd. 002422 SZSE

Hunan Kelun Pharmaceutical is a Chinese pharmaceutical company producing generic and innovative drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Healthy volunteers needed to test safety of experimental drug KLA478 Results expected Sep 2026 (estimated)
New sedative candidate goes Head-to-Head with propofol in early human test Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 4 Not yet recruiting 1 Completed 3

New sedative candidate goes Head-to-Head with propofol in early human test

Symptom relief Not yet recruiting

Researchers are testing an experimental intravenous sedative called KL0011034 in healthy Chinese adults aged 18 to 45. The trial compares continuous infusions of KL0011034 with propofol, a standard sedative, over 1, 2, and 3 hours. Participants are randomly assigned and neither t…

Phase 1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Symptom relief

Last updated Sep 20, 2026 00:00 UTC

Hunan Kelun Pharmaceutical

Upcoming readouts

New sedative candidate goes Head-to-Head with propofol in early human test